PMID- 3365687 OWN - NLM STAT- MEDLINE DCOM- 19880615 LR - 20131121 IS - 0008-5472 (Print) IS - 0008-5472 (Linking) VI - 48 IP - 11 DP - 1988 Jun 1 TI - Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells. PG - 2963-8 AB - The cytosolic aldehyde dehydrogenase (ALDH) isozyme from cyclophosphamide (CPA) resistant L1210 cells (L1210/CPA) was purified to apparent homogeneity using ternary enzyme complex-dye ligand chromatography. The purified isozyme migrates as a single band at Mr 51,000 in sodium dodecyl sulfate polyacrylamide gel electrophoresis and as a single charge species at isoelectric point = 5.8 in isoelectric focusing. Micromolar Km values were estimated with both propionaldehyde (Km = 5 microM) and 4-hydroxy cyclophosphamide (4-OH CPA) (Km = 4 microM) as substrates, indicating that this isozyme is capable of oxidizing the activated cyclophosphamide intermediate 4-hydroxy CPA/aldophosphamide to carboxyphosphamide. This isozyme is also potently inhibited by disulfiram (Ki = 6 microM) and 4-(diethylamino)benzaldehyde (Ki = 0.04 microM). Both of these inhibitors are capable of sensitizing L1210/CPA cells to activated CPA in clonogenic survival assays. Thus, the increased levels of only the cytosolic ALDH isoform in L1210/CPA cells appear to be the single phenotypic difference necessary for conferring resistance to CPA. Monospecific antibodies to the L1210/CPA isozyme have been used in Western blot analysis to detect nanogram levels of ALDH in cell and tissue extracts. These antibodies cross-react with the cytosolic isozyme in P388/CPA cells, mouse liver, mouse small intestine, and the 1C1C7 hepatoma cell line, whereas no ALDH is detected in sensitive L1210 or P388 cells. Also, these antibodies show little cross-reactivity with the mitochondrial isozyme from mouse liver or 1C1C7 cells. From immunological and inhibitor characterization, the soluble ALDH isozyme in L1210/CPA cells appears identical to the normal mouse tissue isozyme. FAU - Russo, J E AU - Russo JE AD - Pharmacology Laboratory, Johns Hopkins Oncology Center, Baltimore, Maryland 21205. FAU - Hilton, J AU - Hilton J LA - eng GR - CA-16783/CA/NCI NIH HHS/United States GR - CA-36966/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Cancer Res JT - Cancer research JID - 2984705R RN - 8N3DW7272P (Cyclophosphamide) RN - EC 1.2.1.3 (Aldehyde Dehydrogenase) SB - IM MH - Aldehyde Dehydrogenase/*isolation & purification/metabolism MH - Animals MH - Cyclophosphamide/pharmacology MH - Cytosol/enzymology MH - Drug Resistance MH - Kinetics MH - Leukemia L1210/*enzymology MH - Mice MH - Mitochondria/enzymology MH - Tumor Stem Cell Assay EDAT- 1988/06/01 00:00 MHDA- 1988/06/01 00:01 CRDT- 1988/06/01 00:00 PHST- 1988/06/01 00:00 [pubmed] PHST- 1988/06/01 00:01 [medline] PHST- 1988/06/01 00:00 [entrez] PST - ppublish SO - Cancer Res. 1988 Jun 1;48(11):2963-8.